ClinicalTrials.Veeva

Menu

rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder

Zhejiang University logo

Zhejiang University

Status

Enrolling

Conditions

Bipolar Disorder in Remission

Treatments

Device: Repetitive Transcranial magnetic stimulation and transcranial alternating current stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05964777
IIT20230058C-R1

Details and patient eligibility

About

Based on the individualized positioning technology of diffusion tensor imaging (DTI), the purpose of this study is to explore a new stimulation target and protocol for the treatment of bipolar disorder in remission through the repetitive transcranial magnetic stimulation(rTMS) and transcranial alternating current stimulation(tACS)under neuronavigation,verify whether there is abnormal functional connectivity and structural connections between the dorsolateral prefrontal cortex (dlpfc) and the dorsal anterior cingulate gyrus (dacc) related to cognitive impairment in bipolar disorder in remission, which will contribute to further understand the relevant neural pathway and mechanism.

Enrollment

54 estimated patients

Sex

All

Ages

14 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Age 14-45 years old, regardless of gender] 2.Meet DSM-V diagnostic criteria for bipolar depressive in remission 3.Young Mania Rating Scale (YMRS) ≤ 6 points; 4.Hamilton Depression Scale(HAMD-17)≤7 points; 5.Cognitive deficit questionnaire PDQ≥17 points; 6.Han nationality, right-handed; 7.More than 9 years of education.

Exclusion criteria

  1. History of severe somatic or brain organic diseases and craniocerebral trauma;
  2. Abnormal brain structure or any MRI contraindications were found by magnetic resonance examination;
  3. Those who do not cooperate or cannot effectively complete the experiment;
  4. Drug, alcohol or other psychoactive substance abusers;
  5. Pregnant, lactating or planned pregnancy;
  6. ECT or rTMS or tACS treatment was performed within six months.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

54 participants in 3 patient groups, including a placebo group

Repetitive Transcranial magnetic stimulation and transcranial alternating current stimulation
Active Comparator group
Description:
rTMS and tACS have a profound impact on cognitive impairment.,The damaged neural circuit of DLPFC-DACC may lead to impaired cognitive function in bipolar disorder.We used DTI imaging technology to calculate the stimulus site.Using high-frequency rTMS and high-precision tACS stimulation,thus affect the nerve ring pathway , thereby rapidly, effectively and safely improving cognitive impairment with bipolar disorder in remission.the subjects were subjected to rTMS for 20 minutes per day with the stimulation intensity of 10Hz and 100% of the motion threshold(MT),stimulation time of each sequence was 5 seconds, stimulation interval was 15 seconds, 3000 pulses per day for 15 days, and the total number of pulses was 45000. tACS has 5 high-precision targets, the total current is 2mA, and the stimulation frequency is 40hz. Under true stimulation, the current fade in and out time is 10 seconds, and the stimulation time is 30 minutes.
Treatment:
Device: Repetitive Transcranial magnetic stimulation and transcranial alternating current stimulation
Repetitive Transcranial magnetic stimulation and sham transcranial alternating current stimulation
Placebo Comparator group
Description:
the subjects were subjected to rTMS for 20 minutes per day with the stimulation intensity of 10Hz and 100% of the motion threshold(MT),stimulation time of each sequence was 5 seconds, stimulation interval was 15 seconds, 3000 pulses per day for 15 days, and the total number of pulses was 45000. tACS has 5 high-precision targets, the total current is 2mA, and the stimulation frequency is 40hz. Under sham stimulation, the current fade in and out time is 10 seconds, the other 29 minutes and 40 seconds, no real current passes through.
Treatment:
Device: Repetitive Transcranial magnetic stimulation and transcranial alternating current stimulation
Sham repetitive Transcranial magnetic stimulation and transcranial alternating current stimulation
Placebo Comparator group
Description:
The stimulus intensity was 20% of MT in the ShamComparator arm, and the remaining parameters were the same as the Active Comparator arm. tACS has 5 high-precision targets, the total current is 2mA, and the stimulation frequency is 40hz. Under true stimulation, the current fade in and out time is 10 seconds, and the stimulation time is 30 minutes.
Treatment:
Device: Repetitive Transcranial magnetic stimulation and transcranial alternating current stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Xiaomei Zhang; ShaoHua Hu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems